Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07011342 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

Study acronym: SCOUT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Collaborator revisedv6
  3. Re-verified, no change to tracked fieldsv5
  4. Start date: Aug 15, 2025 to Oct 1, 2025
    • Primary and study completion dates: Oct 2028 to Nov 2028
    v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: Aug 1, 2025 to Aug 15, 2025
    v3
  6. Start date: Jun 1, 2025 to Aug 1, 2025
    • Primary and study completion dates: Aug 2028 to Oct 2028
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the effectiveness of a PSMA-PET scan in identifying recurrent prostate cancer after focal therapy
Trial Details
NCT Number NCT07011342
Lead Sponsor Hackensack Meridian Health
Collaborators: Blue Earth Diagnostics
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov